Activity and safety of the multi-target tyrosine kinase inhibitor cabozantinib in patients with metastatic gastrointestinal stromal tumour after treatment with imatinib and sunitinib: European Organisation for Research and Treatment of Cancer phase II trial 1317 ‘CaboGIST’

MLA

Bernd Kasper, et al. “Activity and Safety of the Multi-Target Tyrosine Kinase Inhibitor Cabozantinib in Patients with Metastatic Gastrointestinal Stromal Tumour after Treatment with Imatinib and Sunitinib: European Organisation for Research and Treatment of Cancer Phase II Trial 1317 ‘CaboGIST.’” European Journal of Cancer, vol. 134, July 2020, pp. 62–74. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....26f02d2af3918bd12e6b4a892542bb04&authtype=sso&custid=ns315887.

APA

Bernd Kasper, Palma Dileo, Zsuzsanna Papai, Axelle Nzokirantevye, Antoine Italiano, Charlotte Benson, Katerina Kopeckova, Saskia Litière, Isabelle Vanden Bempt, Facundo Zaffaroni, Eva Wardelmann, A. Lecesne, Olivier Mir, Nasim Ali, Agnieszka Wozniak, Patrick Schöffski, Franka Menge, Sandrine Marreaud, Sophie Cousin, … Hans Gelderblom. (2020). Activity and safety of the multi-target tyrosine kinase inhibitor cabozantinib in patients with metastatic gastrointestinal stromal tumour after treatment with imatinib and sunitinib: European Organisation for Research and Treatment of Cancer phase II trial 1317 ‘CaboGIST.’ European Journal of Cancer, 134, 62–74.

Chicago

Bernd Kasper, Palma Dileo, Zsuzsanna Papai, Axelle Nzokirantevye, Antoine Italiano, Charlotte Benson, Katerina Kopeckova, et al. 2020. “Activity and Safety of the Multi-Target Tyrosine Kinase Inhibitor Cabozantinib in Patients with Metastatic Gastrointestinal Stromal Tumour after Treatment with Imatinib and Sunitinib: European Organisation for Research and Treatment of Cancer Phase II Trial 1317 ‘CaboGIST.’” European Journal of Cancer 134 (July): 62–74. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....26f02d2af3918bd12e6b4a892542bb04&authtype=sso&custid=ns315887.